1332 results
Rapid-fire - Combined structural interventions
21 Nov 2023 – From PCR London Valves 2023
Consult this session unraveling the nuances of combined structural interventions, and uncover a unique case of Platypnea-Orthodeoxia syndrome following TAVI, navigate through the complexities of combined TAVR and TMVR in rheumatic heart disease, explore the optimal timing for M-TEER after TAVR in mitral regurgitation, and more!
Rapid-fire - Challenging TAVI procedures - Part 5
21 Nov 2023 – From PCR London Valves 2023
Discover challenging TAVI scenarios in this session: experience the challenges posed by a small annulus with anomalous coronary arteries, delve into the Mitroflow Valve-in-Valve TAVR procedure, witness a unique approach to TAVI in a patient with a mechanical mitral valve, and more!
Rapid-fire - Nightmares in the cathlab - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...
PARTNER 3 Low-Risk trial: 5-year insights on TAVI vs. SAVR outcomes
Alex Sticchi interviews Martin Leon about the five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial, presented at the #TCT23 Congress.
The analysis reveals comparable outcomes for TAVI and SAVR, with nuanced differences favouring each approach. Prof. Leon emphasizes the importance of long-term data...
Unmet clinical need & relevance of intermediate & XL sizes in TAVI
08 Jan 2024 – From PCR London Valves 2023
In this roundtable discussion, Patrick Serruys, Andreas Baumbach, and Christian Juhl Terkelsen explore the innovative concept of intermediate sizes and extra-large valves. They introduce a new valve which is another step forward in addressing the unmet needs of the interventional cardiovascular community.
This interview was filmed at...
How can the latest long-term TAVI evidence impact our daily decision-making?
Join Antoinette Neylon, Didier Tchétché and Ole De Backer as they discuss the key issues in terms of lifetime management of TAVI patients, the learnings from the 10-year TAVI NOTION, the 4-year Evolut Low Risk, and the impact on initial device choice.
This interview was filmed at...
TAVI pathway optimisation in Europe, insights and evidence
29 Nov 2023 – From PCR London Valves 2023
In this roundtable, Francesco Saia, Derk Frank and Douglas Muir discuss the need for TAVI pathway optimisation and Edwards' clinical project called Benchmark program, which comprises the best practices based on the evidence regarding pre- peri-and post-procedural TAVI phases.
This interview was filmed at PCR London Valves...
DurAVR early safety and feasibility of a new class of biomimetic transcatheter aortic valve
05 Dec 2023 – From PCR London Valves 2023
DurAVR is a new TAVR valve which can mimic the shape of an original aortic valve. In this roundtable, Michael Reardon, Christopher Meduri, and Azeem Latib discuss this new technology, its key features, and the unmet medical needs it aims to answer. Find out more about...
Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices
20 Nov 2023 – From PCR London Valves 2023
Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...
Valve in valve - TAVI in SAV - Part 1
20 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in TAVI in SAV with this selection of cases: learn how to manage a degenerated surgical valve using a novel transcatheter heart valve, navigate low-contrast valve-in-valve scenarios in early bioprosthesis failure, witness the adaptability of TAVI valve-in-valve in a severely tortuous and horizontal...
Valve embolism and displacement
20 Nov 2023 – From PCR London Valves 2023
Consult this session to learn innovative strategies and management approaches for valve embolism and displacement: navigate the complexities of challenging severe aortic regurgitation, confront unexpected global myocardial ischemia during TAVI, explore the difficulties of a TAVI procedure in a surgical aortic valve with Evolut FX, and more!
TAVI - New indications, techniques and devices - Part 2
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift overview of evolving TAVI indications and techniques: gain insights into thirty-day outcomes with Evolut FX, stratified by heart team risk, witness the 12-month follow-up of the Valvosoft first-in-man study, uncover sizing considerations in bicuspid tapered aortic valves undergoing TAVI from the...
TAVI - stroke
20 Nov 2023 – From PCR London Valves 2023
Join this session for key perspectives on stroke management and prevention in TAVI: gain a comprehensive view of the long-term outcomes in transfemoral TAVI complicated by stroke, evaluate a novel cerebral embolic protection during TAVI through the PROTEMBO C-TRIAL, learn how TAVR debris captured by CEP...
TAVI - Coronary protection strategies
20 Nov 2023 – From PCR London Valves 2023
Consult this session for key insights into diverse coronary protection approaches: get a look at the management of a complex case involving a degenerated aortic bioprosthesis and paravalvular leak, observe a successful TAVI in calcified bicuspid anatomy with low coronaries, delve into a case featuring a degenerated...
Aortic regurgitation - Part 1
20 Nov 2023 – From PCR London Valves 2023
Delve into key insights on aortic regurgitation with this selection of abstracts: explore a systematic review and meta-analysis on TAVI for aortic regurgitation using dedicated devices, witness video-densitometric analysis of aortic regurgitation post-JenaValve Trilogy treatment, discover a small case series on TAVI in the descending thoracic...
TAVI - New indications, techniques and devices - Part 3
20 Nov 2023 – From PCR London Valves 2023
Explore the latest in TAVI with this selection of abstracts: witness the application of valve-in-valve TAVI for failed sutureless surgical bioprostheses and gain insights from the analysis of the use and performance of the Evolut FX transcatheter aortic valve system.
TAVI - Alternative access - Part 2
20 Nov 2023 – From PCR London Valves 2023
Delve into alternative access strategies in TAVI with this session: navigate through cases featuring complex aortic anatomy in TAVI patients, witness the innovative use of intravascular lithotripsy of the abdominal aorta to facilitate transcaval valve-in-valve TAVR and explore the technique of transseptal TAVR.
Complex tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Consult this session to discover a selection of abstracts regarding tricuspid valve procedures: explore the complexities of long-term right heart remodeling after transcatheter tricuspid annuloplasty, witness the journey from pre-clinical studies to the first-in-man experience with MonarQ tricuspid valve replacement, delve into Tripair, an innovative transcatheter spacer...
TAVI in patients with coronary artery disease
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift overview of navigating TAVI complexities in the presence of coronary artery disease: navigate through cases involving the management of severe aortic stenosis coupled with stable severe coronary artery disease, explore scenarios where valvular and coronary calcium present challenges, witness successful treatment...
TAVI in unusual clinical scenarios
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift exploration of TAVI applications in unexpected clinical contexts: witness the challenges of TAVR in a patient with mucopolysaccharidosis type I, navigate through the complexities of TAVI in an orthotopic heart transplant recipient, explore the feasibility of TAVI in rheumatic severe...
